Evidence map›Paper›PMID 31541120›Full record

ArticleScientific reports2019

Emerging recombination of the C2 sub-genotype of HFMD-associated CV-A4 is persistently and extensively circulating in China.

Tianjiao Ji, Yue Guo, Likun Lv, Jianxing Wang, Yong Shi, Qiuli Yu, Fan Zhang, Wenbin Tong, Jiangtao Ma, Hanri Zeng and 9 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 1 country.

Tianjiao JiNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), Beijing, People's Republic of China.
Yue GuoNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), Beijing, People's Republic of China.
Likun LvTianjin Municipal Center for Disease Control and Prevention, Tianjin Municipal, People's Republic of China.
Jianxing WangShandong Center for Disease Control and Prevention, Shandong Province, People's Republic of China.
Yong ShiJiangxi Center for Disease Control and Prevention, Nanchang, Jiangxi Province, People's Republic of China.
Qiuli YuHebei Center for Disease Control and Prevention, Shijiazhuang, Hebei Province, People's Republic of China.
Fan ZhangHunan Center for Disease Control and Prevention, Changsha, Hunan Province, People's Republic of China.
Wenbin TongSichuan Center for Disease Control and Prevention, Chengdu, Sichuan Province, People's Republic of China.
Jiangtao MaNingxia Center for Disease Control and Prevention, Yinchuan, Ningxia Province, People's Republic of China.
Hanri ZengGuangdong Center for Disease Control and Prevention, Guangzhou, Guangdong Province, People's Republic of China.
Hua ZhaoChongqing Center for Disease Control and Prevention, Chongqing Municipal, People's Republic of China.
Yong ZhangNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), Beijing, People's Republic of China.ORCID http://orcid.org/0000-0002-2692-5437
Taoli HanNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), Beijing, People's Republic of China.
Yang SongNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), Beijing, People's Republic of China.
Dongmei YanNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), Beijing, People's Republic of China.
Qian YangNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), Beijing, People's Republic of China.
Shuangli ZhuNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), Beijing, People's Republic of China.
Yan ZhangNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), Beijing, People's Republic of China. zhangyan9876543@163.com.
Wenbo XuNHC Key Laboratory of Medical Virology and Viral Diseases (National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention), Beijing, People's Republic of China. wenbo_xu1@aliyun.com.
National Institute for Viral Disease Control and Prevention · CNChongqing Municipal Government · CNHebei Provincial Center for Disease Control and Prevention · CNHunan Provincial Center for Disease Control and Prevention · CNNanchang Center for Disease Control and Prevention · CNNingxia Center for Diseases Prevention and Control · CNShandong Center for Disease Control and Prevention · CNSichuan Center for Disease Control and Prevention · CNTianjin Municipal Engineering Design and Research Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sporadic outbreaks caused by coxsackievirus A4 (CV-A4) have been reported worldwide. To further elucidate the detailed genetic characteristics and evolutionary recombination events of CV-A4, virus samples from nationwide hand, foot and mouth disease (HFMD) surveillance, encompassing 27 out of the 31 provinces in China, were investigated. Comprehensive and systematic phylogenetic analyses were performed by using 29 complete genomes, 142 complete CV-A4 VP1 sequences. Four genotypes (A, B, C and D) and five sub-genotypes (C1-C5) were re-identified based on the complete VP1 sequences. C2 is the predominant sub-genotype of CV-A4 associated with HFMD and has evolved into 3 clusters. Cluster 1 is a major cluster that has been persistently and extensively circulating in China since 2006 and has been associated with all severe cases. All the sequences showed high homology with the CV-A4 prototype in the P1 region, while higher identities with CV-A5, CV-14 and CV-16 in the P2 and P3 regions. Recombination analysis revealed that C2 had two specific genetic recombination patterns with other EV-A prototypes in the 5'-UTR and 3D region compared with C5. These recombination patterns might be associated with the increased transmissibility of C2 viruses, which were obtained due to their persistent and extensive circulation in populations.

Indexed as

Capsid ProteinsCell LineChinaEnterovirus A, HumanEvolution, MolecularGenome, ViralGenotypeHand, Foot and Mouth DiseaseHumansPhylogenyPopulation SurveillanceRecombination, GeneticSequence Analysis, RNASequence Homology, Nucleic AcidCapsid ProteinsVP1 protein, Foot-and-mouth disease virus

Identifiers

PMID31541120
PMCPMC6754396
OpenAlexW2974184247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.